Literature DB >> 8836881

Non-RGD domains of osteopontin promote cell adhesion without involving alpha v integrins.

Y U Katagiri1, M Murakami, K Mori, J Iizuka, T Hara, K Tanaka, W Y Jia, A F Chambers, T Uede.   

Abstract

Osteopontin (OPN) is an integrin-binding secreted protein that contains an Arg-Gly-Asp (RGD) amino acid sequence and binds to various cell types via RGD-mediated interaction with the alpha v beta 3 integrin. We have identified a cell line whose binding to OPN does not require RGD or alpha v interactions. We compared the ability of two murine cell lines, L929 fibroblastic cells and B16-BL6 melanoma cells, to interact with OPN (from human milk, and recombinant human and mouse OPN) as well as recombinant OPN prepared to include either the N-terminal or C-terminal halves but lacking the RGD sequence. Both cell lines adhered to GRGDS peptides coupled to BSA, and these interactions were inhibited by addition of GRGDS (but not GRGES) peptides or a monoclonal antibody specific to the alpha v integrin subunit. Adhesion of L929 cells to OPN was also dependent on the RGD sequence and the alpha v integrin subunit. However, the binding of B16-BL6 cells was not inhibited by either GRGDS peptides or the anti-alpha v antibody. B16-BL6 (but not L929) cells were also able to adhere to and spread on both N-terminal and C-terminal OPN proteins that lack the RGD sequence, and these interactions were not inhibited by either GRGDS peptides or anti-alpha v antibody. Together these results indicate that B16-BL6 cells can adhere to OPN by interactions that are independent of either the RGD sequence or the alpha v integrin subunit, and suggest that some cells can interact with additional, non-RGD binding sites in OPN.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8836881     DOI: 10.1002/(sici)1097-4644(199607)62:1<123::aid-jcb13>3.0.co;2-o

Source DB:  PubMed          Journal:  J Cell Biochem        ISSN: 0730-2312            Impact factor:   4.429


  7 in total

Review 1.  Intracellular osteopontin (iOPN) and immunity.

Authors:  Makoto Inoue; Mari L Shinohara
Journal:  Immunol Res       Date:  2011-04       Impact factor: 2.829

2.  The cytokine osteopontin modulates the severity of rotavirus diarrhea.

Authors:  Ellen E Rollo; Scott J Hempson; Ajay Bansal; Ernest Tsao; Iman Habib; Susan R Rittling; David T Denhardt; Erich R Mackow; Robert D Shaw
Journal:  J Virol       Date:  2005-03       Impact factor: 5.103

3.  Osteopontin regulates multiple functions contributing to human colon cancer development and progression.

Authors:  R B Irby; S M McCarthy; T J Yeatman
Journal:  Clin Exp Metastasis       Date:  2004       Impact factor: 5.150

4.  Effect of osteopontin alleles on beta-glucan-induced granuloma formation in the mouse liver.

Authors:  Kumiko Tanaka; Junko Morimoto; Shigeyuki Kon; Chiemi Kimura; Manabu Inobe; Hongyan Diao; Gregor Hirschfeld; Johannes M Weiss; Toshimitsu Uede
Journal:  Am J Pathol       Date:  2004-02       Impact factor: 4.307

5.  Cancer biomarker discovery: the entropic hallmark.

Authors:  Regina Berretta; Pablo Moscato
Journal:  PLoS One       Date:  2010-08-18       Impact factor: 3.240

6.  Osteopontin is involved in the initiation of cutaneous contact hypersensitivity by inducing Langerhans and dendritic cell migration to lymph nodes.

Authors:  J M Weiss; A C Renkl; C S Maier; M Kimmig; L Liaw; T Ahrens; S Kon; M Maeda; H Hotta; T Uede; J C Simon
Journal:  J Exp Med       Date:  2001-11-05       Impact factor: 14.307

7.  Thrombin cleavage of osteopontin initiates osteopontin's tumor-promoting activity.

Authors:  Sameera Peraramelli; Qi Zhou; Qin Zhou; Bettina Wanko; Lei Zhao; Toshihiko Nishimura; Thomas H Leung; Seiya Mizuno; Mamoru Ito; Timothy Myles; Thomas M Stulnig; John Morser; Lawrence L K Leung
Journal:  J Thromb Haemost       Date:  2022-02-16       Impact factor: 16.036

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.